ID   A10.7
AC   CVCL_E301
AS   CVCL_D552
SY   LZ10.7; E3LZ10.7; Pa03C
DR   AddexBio; C0018005/168
DR   AddexBio; C0018006/288
DR   ChEMBL-Cells; CHEMBL4483156
DR   ChEMBL-Targets; CHEMBL4483263
DR   Cosmic; 1473117
DR   Cosmic; 1509850
DR   PubChem_Cell_line; CVCL_E301
DR   Wikidata; Q54606243
RX   PubMed=17332349;
RX   PubMed=17912029;
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
RX   PubMed=17332349; DOI=10.1158/0008-5472.CAN-06-3281;
RA   Feldmann G., Dhara S., Fendrich V., Bedja D., Beaty R., Mullendore M.,
RA   Karikari C., Alvarez H., Iacobuzio-Donahue C.A., Jimeno A.,
RA   Gabrielson K.L., Matsui W., Maitra A.;
RT   "Blockade of hedgehog signaling inhibits pancreatic cancer invasion
RT   and metastases: a new paradigm for combination therapy in solid
RT   cancers.";
RL   Cancer Res. 67:2187-2196(2007).
//
RX   PubMed=17912029; DOI=10.4161/cbt.6.10.4708;
RA   Fu B.-J., Guo M.-Z., Wang S.-L., Campagna D., Luo M.-D., Herman J.G.,
RA   Iacobuzio-Donahue C.A.;
RT   "Evaluation of GATA-4 and GATA-5 methylation profiles in human
RT   pancreatic cancers indicate promoter methylation patterns distinct
RT   from other human tumor types.";
RL   Cancer Biol. Ther. 6:1546-1552(2007).
//
RX   PubMed=22753594; DOI=10.1158/1078-0432.CCR-12-0827;
RA   Cui Y.-F., Brosnan-Cashman J.A., Blackford A.L., Sur S., Hruban R.H.,
RA   Kinzler K.W., Vogelstein B., Maitra A., Diaz L.A. Jr.,
RA   Iacobuzio-Donahue C.A., Eshleman J.R.;
RT   "Genetically defined subsets of human pancreatic cancer show unique in
RT   vitro chemosensitivity.";
RL   Clin. Cancer Res. 18:6519-6530(2012).
//